Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/30773

Type
Article
Copyright
Restricted access
Embargo date
2030-01-01
Sustainable Development Goals
03 Saúde e Bem-Estar
Collections
Share

Statistics
Metadata
Show full item record

SHOULD BRAZILIAN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION BE VACCINATED AGAINST HEPATITIS A VIRUS?
Villar, Livia M. et al. | Date Issued: 2009
Author
Villar, Livia M.
Melo, Maria M. M. de
Calado, Izabelle A.
Almeida, Adilson J. de
Lampe, Elisabeth
Gaspar, Ana M. C.
Affilliation
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil.
Laboratório Central de Saúde Pública do Estado de Pernambuco. PE, Brasil.
Laboratório Central de Saúde Pública do Estado de Pernambuco. PE, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatites Virais. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Hepatiyes Virais. Rio de Janeiro, RJ, Brasil.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Tecnologia Viral. Rio de Janeiro, RJ, Brasil.
Abstract
Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in patients with hepatitis C virus (HCV) infection. The aim of this study was to investigate the presence of serological and molecular HAV markers in a population of HCV-infected patients in order to determine a cost-effective strategy to vaccinate against HAV.
Keywords in Portuguese
Vìrus da Hepatite A
Vírus da Hepatite C
Vacinação
 
Keywords
hepatitis A virus
hepatitis C virus
Vaccination
 
Publisher
Wiley
Citation
VILLAR, Livia M. et al. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?. Hepatology, v.24,p.238-242, 2009.
DOI
10.1111/j.1440-1746.2008.05575.x
ISSN
0270-9139